EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

J Y Blay, C Tlemsani, M Toulmonde, A Italiano, M Rios, E Bompas, T Valentin, F Duffaud, L R Le Nail, S Watson, N Firmin, P Dubray-Longeras und 34 weitere

European Journal of Cancer · 2024-01 · 196 · 113454

DOI: 10.1016/j.ejca.2023.113454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2024-01. Verfasst von J Y Blay und 45 weiteren Autor:innen. Beteiligte Einrichtung: Centre Léon Bérard & Université Claude Bernard, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr. Hauptthemen laut MEDLINE: Fibrosarcoma, Sarcoma, Soft Tissue Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Cancer Institute, European Network for Rare Adult Solid Cancers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosarcomaSarcomaSoft Tissue NeoplasmsHumansFemaleChildMaleGene RearrangementRecurrence

Stichwörter der Autor:innen

GuidelinesLow grade fibromyxoid sarcomaRare cancersReference centersSarcomaSclerosing epithelioid fibrosarcomaSurvival

Autor:innen und Institutionen

  • Centre Léon Bérard & Université Claude Bernard, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
  • Hopital Cochin, Paris, France.
  • Departement of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Institut Cancerologie Lorraine, Centre Alexis Vautrin, Nancy, France.
  • Department of Medical Oncology, Institut de Cancerologie Ouest Nantes, France.
  • Institut Claudius Regaud & Institut Universitaire de Cancerologie, Oncopole, Toulouse, France.

Förderung

  • French National Cancer Institute
  • European Network for Rare Adult Solid Cancers

Zitieren

APA

Blay, J. Y., Tlemsani, C., Toulmonde, M., Italiano, A., Rios, M., Bompas, E., Valentin, T., Duffaud, F., Le Nail, L. R., Watson, S., Firmin, N., Dubray-Longeras, P., Ropars, M., Perrin, C., Hervieu, A., Lebbe, C., Saada-Bouzid, E., Soibinet, P., Fiorenza, F., …, & NETSARC/REPPS/RESOS and French Sarcoma Group- Groupe d′Etude des Tumeurs Osseuses (GSF-GETO) networks (2024). Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years. European Journal of Cancer, 196, 113454. https://doi.org/10.1016/j.ejca.2023.113454

Vancouver

Blay JY, Tlemsani C, Toulmonde M, Italiano A, Rios M, Bompas E, et al. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years. European Journal of Cancer. 2024;196:113454. doi:10.1016/j.ejca.2023.113454

BibTeX
@article{Blay2024,
  author = {Blay, J Y and Tlemsani, C and Toulmonde, M and Italiano, A and Rios, M and Bompas, E and Valentin, T and Duffaud, F and Le Nail, L R and Watson, S and Firmin, N and Dubray-Longeras, P and Ropars, M and Perrin, C and Hervieu, A and Lebbe, C and Saada-Bouzid, E and Soibinet, P and Fiorenza, F and Bertucci, F and Boudou, P and Vaz, G and Bonvalot, S and Honoré, C and Marec-Berard, P and Minard, V and Cleirec, M and Biau, D and Meeus, P and Babinet, A and Dumaine, V and Carriere, S and Fau, M and Decanter, G and Gouin, F and Ngo, C and Le Loarer, F and Karanian, M and Meurgey, A and Dufresne, A and Brahmi, M and Chemin-Airiau, C and Ducimetiere, F and Penel, N and Le Cesne, A and NETSARC/REPPS/RESOS and French Sarcoma Group- Groupe d′Etude des Tumeurs Osseuses (GSF-GETO) networks, NETSARC/REPPS/RESOS and French Sarcoma Group- Groupe d′Etude des Tumeurs Osseuses (GSF-GETO) networks},
  title = {Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {196},
  pages = {113454},
  doi = {10.1016/j.ejca.2023.113454}
}
Kostenlos starten →